The results of an analysis of suspected antiviral-associated adverse drug reactions (ADRs) in Italy over a 22-year period are presented.A case/non-case analysis was conducted using ADR reports compiled in the nationwide spontaneous-reporting database through September 2010. All reported events included in the analysis were evaluated and coded by drug safety experts; causality assessments were performed according to the algorithm of Naranjo et al. The association between an adverse reaction and antiviral use was assessed by estimating the reporting odds ratio (ROR), with 95\% confidence interval (CI), as a measure of disproportionality.Overall, 863 reports of suspected ADRs involving antivirals and 42,430 reports of adverse reactions to other drugs were identified; of those events, 3.3\% and 64.3\% were determined to be definite or probable ADRs, respectively, and an additional 32.4\% were deemed possibly drug related. Several ADRs were disproportionately associated with antivirals relative to other drugs: renal colic (ROR, 25.5; 95\% CI, 13.3-49.0), lactic acidosis (ROR, 18.6; 95\% CI, 9.2-37.7), depression (ROR, 18.0; 95\% CI, 11.6-27.9), anemia (ROR, 15.9; 95\% CI, 12.3-20.4), hallucination (ROR, 4.3; 95\% CI, 2.7-7.1), neutropenia (ROR, 4.1; 95\% CI, 2.9-5.8), acute renal failure (ROR, 3.9; 95\% CI, 2.3-6.4), fever (ROR, 3.8; 95\% CI, 2.8-5.1), hyperpyrexia (ROR, 2.9; 95\% CI, 1.7-4.9), and asthenia (ROR, 1.8; 95\% CI, 1.2-2.8).Analysis of data from a large Italian database showed that, among antiviral agents, the ribavirin-interferon combination, acyclovir, valacyclovir, indinavir, and zidovudine accounted for the most serious hematologic, neuropsychiatric, and renal ADRs.

Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database / A. Pugi;R. Bonaiuti;V. Maggini;M. Moschini;M. Tuccori;R. Leone;M. Rossi;D. Motola;C. Piccinni;F. Ferrazin;L. Sottosanti;A. Mugelli;A. Vannacci;F. Lapi. - In: AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY. - ISSN 1079-2082. - ELETTRONICO. - 70:(2013), pp. 1039-1046. [10.2146/ajhp120665]

Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database.

PUGI, ALESSANDRA;BONAIUTI, ROBERTO;MAGGINI, VALENTINA;MOSCHINI, MARTINA;MUGELLI, ALESSANDRO;VANNACCI, ALFREDO;LAPI, FRANCESCO
2013

Abstract

The results of an analysis of suspected antiviral-associated adverse drug reactions (ADRs) in Italy over a 22-year period are presented.A case/non-case analysis was conducted using ADR reports compiled in the nationwide spontaneous-reporting database through September 2010. All reported events included in the analysis were evaluated and coded by drug safety experts; causality assessments were performed according to the algorithm of Naranjo et al. The association between an adverse reaction and antiviral use was assessed by estimating the reporting odds ratio (ROR), with 95\% confidence interval (CI), as a measure of disproportionality.Overall, 863 reports of suspected ADRs involving antivirals and 42,430 reports of adverse reactions to other drugs were identified; of those events, 3.3\% and 64.3\% were determined to be definite or probable ADRs, respectively, and an additional 32.4\% were deemed possibly drug related. Several ADRs were disproportionately associated with antivirals relative to other drugs: renal colic (ROR, 25.5; 95\% CI, 13.3-49.0), lactic acidosis (ROR, 18.6; 95\% CI, 9.2-37.7), depression (ROR, 18.0; 95\% CI, 11.6-27.9), anemia (ROR, 15.9; 95\% CI, 12.3-20.4), hallucination (ROR, 4.3; 95\% CI, 2.7-7.1), neutropenia (ROR, 4.1; 95\% CI, 2.9-5.8), acute renal failure (ROR, 3.9; 95\% CI, 2.3-6.4), fever (ROR, 3.8; 95\% CI, 2.8-5.1), hyperpyrexia (ROR, 2.9; 95\% CI, 1.7-4.9), and asthenia (ROR, 1.8; 95\% CI, 1.2-2.8).Analysis of data from a large Italian database showed that, among antiviral agents, the ribavirin-interferon combination, acyclovir, valacyclovir, indinavir, and zidovudine accounted for the most serious hematologic, neuropsychiatric, and renal ADRs.
2013
70
1039
1046
A. Pugi;R. Bonaiuti;V. Maggini;M. Moschini;M. Tuccori;R. Leone;M. Rossi;D. Motola;C. Piccinni;F. Ferrazin;L. Sottosanti;A. Mugelli;A. Van...espandi
File in questo prodotto:
File Dimensione Formato  
antivirali.pdf

Accesso chiuso

Descrizione: Articolo
Tipologia: Pdf editoriale (Version of record)
Licenza: Creative commons
Dimensione 3.63 MB
Formato Adobe PDF
3.63 MB Adobe PDF   Richiedi una copia

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/818109
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 10
social impact